エピソード

  • The Role of Anterior Segment OCT in MIGS

    The Role of Anterior Segment OCT in MIGS
    2025/08/22
    Neeru A. Vallabh, MBBS, FRCOphth, PhD, FEBOS-GL, recaps her article, “The Role of Anterior Segment OCT in MIGS,” which was featured in the March/April issue of Glaucoma Today. Dr. Vallabh explores how this mode of advanced imaging can enhance the patient evaluation and surgical results, reviewing its utility for preoperative evaluation and intraoperative adjustments and its ability to provide insights into postoperative outcomes.
    続きを読む 一部表示
    9 分
  • Sustained Drug Delivery in Interventional Glaucoma

    Sustained Drug Delivery in Interventional Glaucoma
    2025/08/15
    I. Paul Singh, MD; Constance Okeke, MD, MSCE; and Zarmeena Vendal, MD, convene to discuss the latest updates on drug delivery and procedural pharmaceuticals in glaucoma treatment—specifically regarding the intracameral bimatoprost implant (Durysta, AbbVie) and iDose TR (travoprost intracameral implant) 75 mcg (Glaukos). They each explain the role of these treatments in their practices and how to identify the noncompliant patients who are the best candidates for this intervention. They also review safety data behind these treatments and share pearls for getting started. Editorially independent content supported with advertising by Glaukos.
    続きを読む 一部表示
    38 分
  • A Cilioscleral Interpositioning Device

    A Cilioscleral Interpositioning Device
    2025/07/28
    Andrew Tatham, MD, MBA, FRCOphth, FEBO, CertLRS, recaps his article, “A Cilioscleral Interpositioning Device,” which was featured in the March/April issue of Glaucoma Today and explores a novel class of glaucoma surgery that targets the supraciliary space. The Intercil Uveal Spacer from Ciliatech represents this new class of surgical implants known as cilioscleral interpositioning devices, or CIDs, which enhance uveoscleral outflow to lower IOP.
    続きを読む 一部表示
    9 分
  • Survey Says: Choosing Treatment for a High-Risk Patient

    Survey Says: Choosing Treatment for a High-Risk Patient
    2025/06/26
    On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.
    続きを読む 一部表示
    35 分
  • Career Change: Making the Vision Come to Life • Private Practice Versus Academia

    Career Change: Making the Vision Come to Life • Private Practice Versus Academia
    2025/05/23
    In this episode, two Glaucoma Today contributors dive into the topic of career paths in ophthalmology, comparing different options and offering pearls from their own experiences. Zahra Ali, MD, recaps her article, “Career Change: Making the Vision Come to Life,” which chronicles her personal transition from general ophthalmologist to glaucoma specialist. Then, Devang L. Bhoiwala, MD, recaps his article, “Private Practice Versus Academia,” which outlines the pros and cons of these two distinct career paths.
    続きを読む 一部表示
    15 分
  • Metabolic Dysfunction in Glaucoma

    Metabolic Dysfunction in Glaucoma
    2025/04/28
    Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.
    続きを読む 一部表示
    29 分
  • Survey Says: Proceeding After Unsuccessful Treatment

    Survey Says: Proceeding After Unsuccessful Treatment
    2025/03/19
    On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Manjool Shah, MD, and Ticiana De Francesco, MD, to review a real case from his practice. They discuss the patient’s treatment history and how it informs which procedures to consider for the future and which ones to rule out. The guests share how they would proceed before finding out what Dr. Singh did and how their colleagues would approach the case, based on results of a social media poll of GT’s audience.
    続きを読む 一部表示
    26 分
  • Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation

    Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation
    2025/02/24
    Catherine Johnson, MD, MPH, recaps her article, “Impact of Selective Laser Trabeculoplasty on Diurnal IOP Fluctuation,” which was written with Barbara Wirostko, MD, FARVO, and featured in the November/December issue of Glaucoma Today. Home tonometry data are shedding light on SLT’s effect on IOP spikes in the months following laser treatment. This article reviews diurnal IOP fluctuation before and after SLT and discusses the implications of home tonometry in research.
    続きを読む 一部表示
    8 分